InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,612.80
(
0.00%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
81.87
(
-1.21%
)
Bitcoin
62,136.08
(
-0.31%
)
Post# of 173
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Bobwins

Send PM Follow Ignore
Followers 556
Posts 17434
Boards Moderated 42
Alias Born 10/21/2003

Bobwins

Re: Minding post# 85

Tuesday, 10/20/2015 11:51:31 AM

Tuesday, October 20, 2015 11:51:31 AM

Post# of 173
no problem. Certainly the ability of PESI to bring out a workable commercial process in a timely manner is the key to the medical division of the company. They are approaching a pivot point in the production of this vital substance for an entire industry. Will PESI create a new source that takes over the industry or will they be unable to successfully build a commercial model that gets sold?

That's the big question that PESI and several other competitors are trying to find out. It's surely not a slam dunk. Everything points to a successful result but it hasn't happened yet.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PESI News
More PESI News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!